Brent L Kreider (Brent Kreider)

Years Active: 2020-2022
Publications (10 Years): 2

Stowers Institute for Medical Research

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Stowers Institute for Medical Research

United States

Chief Operating Officer

Biomed Valley Discoveries Inc

United States

Chief Operating Officer

Publications

Romain Sigaud, Lisa Rösch, Charlotte Gatzweiler, Julia Benzel, Laura von Soosten, Heike Peterziel, Florian Selt, Sara Najafi, Simay Ayhan, Xenia F Gerloff, Nina Hofmann, Isabel Büdenbender, Lukas Schmitt, Kathrin I Foerster, Juergen Burhenne, Walter Emil Haefeli, Andrey Korshunov, Felix Sahm, Cornelis M van Tilburg, David T W Jones, Stefan M Pfister, Deborah Knoerzer, Brent L Kreider, Max Sauter, Kristian W Pajtler, Marc Zuckermann, Ina Oehme, Olaf Witt, Till Milde
The first-in-class ERK inhibitor ulixertinib shows promising activity in MAPK-driven pediatric low-grade glioma models. Neuro-oncology (2022)
Filip Janku, Halle Huihong Zhang, Abdulmohammad Pezeshki, Sanjay Goel, Ravi Murthy, Andrea Wang-Gillam, Dale R Shepard, Thorunn Helgason, Tyler Masters, David S Hong, Sarina A Piha-Paul, Daniel D Karp, Mark G Klang, Steven Y Huang, Divya Sakamuri, Anjali Raina, Jean Torrisi, Stephen B Solomon, Alice Weissfeld, Ernest Trevino, Gary DeCrescenzo, Amanda Collins, Maria Miller, Jennifer L Salstrom, Ronald L Korn, Linping Zhang, Saurabh Saha, Alexey A Leontovich, David Tung, Brent L Kreider, Mary Varterasian, Khashayarsha Khazaie, Mrinal M Gounder
Intratumoral Injection of Clostridium novyi-NT Spores in Patients with Treatment-refractory Advanced Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (1) (2020)

Brent L Kreider.css-eqlu8i{font-size:small;padding-left:4px;} (Brent Kreider)